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Cancer in developing countries is a growing and soon to be a major problem as life expectancy in-creases. There are 11 million documented cancer 
cases worldwide, and more than half (6 million) occur in 
low and middle income countries. The American Cancer 
Society estimates that this number will increase to 27 
million cases by 2050, mainly due to a growing and aging 
population.1 Cancer is now the second leading cause of 
death from chronic disease after cardiovascular disease 
in developing countries. Five of 7.5 million global can-
cer deaths occurred in the developing world in 2007. At 
the World Health Assembly in 2005, the World Health 
Organization (WHO) passed a resolution calling for 
improved cancer prevention measures, early detection 
and treatment in all WHO member state countries. The 
Institute of Medicine produced a report in 2007, with in-
ternational input on opportunities for cancer control in 
low- and middle-income countries. This report provides 
an excellent global summary of cancer control strategies 
and dispels the idea that we need to conquer infectious 
diseases before turning to chronic diseases. One conclu-
sion is that without support from the developed world, it 
is unlikely that low income countries will make any sig-
nificant progress in cancer control.2 
Needs Assessment
Why expend so much effort to develop an oncology pro-
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cancer in developing countries is growing and will soon be a major problem as life expectancy increases. 
this article outlines the experience and future objectives of a partnership between Yemeni and canadian 
oncology professionals in their attempt to develop a national oncology program in Yemen. We review 
current knowledge of the epidemiology, social, educational and economic challenges as well as sug-
gested initial steps in developing a relevant oncology program for this society. 
gram in developing countries when there are so many 
other greater threats to health in these societies? Using 
Yemen as a case in point, it should be noted that it is 
also very costly not to provide cancer care inasmuch as 
the affluent classes will seek treatment abroad at inter-
national market prices while those who cannot afford to 
seek treatment will suffer and die prematurely, also a cost 
to the nation. The Yemeni government recognized some 
time ago that it would be necessary to develop a national 
strategy in order to focus on cancer prevention, diagnosis 
and treatment in an orderly way. At the time there was 
no facility or organization specifically devoted to cancer 
care. By the beginning of the decade there was activity to-
ward development of a first cancer treatment facility. The 
acquisition of a first team of technical and professional 
experts came to be seen as the core of a future nationwide 
network of centres; the current reality on the ground is 
the National Oncology Centre (NOC) in Sana’a. 
Although there are significant declines in cancer mor-
tality in the developed world, establishing an infrastruc-
ture for cancer prevention, screening, diagnosis and treat-
ment requires time. The investment needed to achieve 
these goals is significant, but there are many low cost, 
high benefit approaches that can be initially undertaken. 
For instance, major reductions in pediatric cancer mor-
tality have occurred in developing countries, particularly 
through partnerships with established pediatric oncology 
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centers from developed countries; Yemen has one of the 
highest proportions of young children in the world with 
almost half the population being under age 15. 
The true cancer incidence in Yemen is unknown 
due to limited resources for pathology, the scarcity and 
quality of medical records, and limited epidemiology 
resources, but most importantly because cancer is of-
ten hidden. Limited experience from Bawazir and the 
NOC suggest that most common cases (generally at 
advanced stage) include head and neck, especially naso-
pharynx, breast, gastrointestinal (especially esophagus 
and gastric, colorectal, hepatocellular carcinoma), lym-
phomas, cervical, testicular and pediatric cancers.3-5 The 
WHO online infobase estimates a total of 10 000 can-
cer deaths in Yemen in 2005 with 8000 of these occur-
ring before age 70. Cancer deaths in Yemen accounted 
for about 5.6% of all deaths in 2005 and are projected 
to reach 8.4% in 2030, overshadowed by communicable 
and cardiovascular diseases.6 Lung cancer is not promi-
nent although a lack of diagnostic facilities may under-
estimate its true incidence. In Yemen, most tobacco is 
not smoked but is chewed. Tobacco use was close to 
20% in the Youth Tobacco Survey.7 
Current Status 
Five percent of per capita GDP ($82) was spent on health 
care in 2004 (Table 1).8 On the positive side, immuni-
zation against childhood diseases is rapidly improving. 
UNICEF was able to provide three doses of hepatitis B 
vaccine for two dollars, which can be subsidized through 
the Global Alliance for Disease and Immunization. The 
WHO national coverage rate for hepatitis B was 86% in 
2005 compared with 49% in 2004. The true incidence 
of human papilloma virus (HPV) and human immu-
nodefiency virus (HIV) is uncertain, but a recent and 
growing Somali refugee population in the south has re-
sulted in the need for HIV clinics in Mukalla.9 There 
is a dire shortage of health workers in all medical fields 
and no specific in-country oncology training programs 
currently exist. There are few cancer screening facili-
ties. Demand for systemic and radiation therapies is 
increasing rapidly, but the availability is limited. Some 
cancer treatment products paid by the government re-
quire approval by the Ministry of Health. Increasingly, 
these consist of drugs produced by firms in developing 
countries although there are concerns regarding their ef-
ficacy, safety and immunogenicity.10-12
Discussion: Lessons Learned
This article outlines the experience of a partnership 
between Yemeni and Canadian oncology profession-
als toward the development of a Yemeni Oncology 
Program. The CMD (Canadian Medical Delegation) 
is an informal group of oncology professionals pri-
marily from the University of Western Ontario, who 
first participated in development of a vision for cancer 
care in 1989, a topic to which we were again directed 
in 2001. The first oncology centre (NOC, Sana’a) was 
opened in February 2005. More than two hundred pa-
tients now receive treatment daily. Plans are underway 
to open additional centres in the country’s major cit-
ies. The CMD provides ongoing input to the oncology 
program through mentorship, training and consulta-
tion. A “SWOT” analysis for this undertaking is sum-
marized in Table 2. 
The relationship between the CMD and their Yemeni 
counterparts has been based on mutual respect and learn-
ing as well as the ability to look for flexible solutions “out-
side the box”. Some of the planned initiatives include the 
following: 
1.  Creating the optimal template with the development 
of the NOC, Sana’a. This will be the initial in-coun-
try training centre for oncology professionals and 
provide leadership for a national program with the 
creation of several additional centres across Yemen. 
2.  Promoting a hospital-based cancer registry in the re-
gions surrounding cancer centres. 
3.  Preliminary determination of cancer risk factors. This 
Table 1. Health statistics for Yemen.
Per capita GDP $1,000
Percent of GDP spent on health care 5.0%
Average life expectancy (years) 62.5
rural population 75%
Illiteracy rate (m/F)% 29.8% / 62.1%
Unemployment rate 35%
Tobacco use (grade 7-9) 16-21%
Prevention programs Hepatitis B immunization
National Cancer registry No
medical schools 5
Health human resources /1,000
   Physicians 0.33
   Nurses 0.64
   Pharmacists 0.13
Oncology facilities 1
radiation oncology units 1
Yemen Poverty Assessment report 2007. The World Bank. Available from: http://
go.worldbank.org/22NHVZB8W0.
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can implemented by itself or as part of a tool such as 
the WHO STEPwise approach by each cancer cen-
tre.13 This approach uses a chronic disease risk factor 
surveillance tool using sequential collection starting 
with core data from health questionnaires, physical 
measurements and eventually blood samples as nec-
essary to determine risks for development of chronic 
diseases. It uses a representative sample of the study 
population which can then be generalized to a larger 
population. 
4.  Implementing a month-long observer program in 
Canada for Yemeni oncologists so that they may ap-
preciate practices that enhance cancer care, including 
safety standards, multidisciplinary case conferences, 
guidelines for care, and protocols for treatment. Our 
experience in developing standards for the safe han-
dling of cytotoxics, the delivery of regional systemic 
therapy and multidisciplinary cancer conferences al-
though developed by Cancer Care Ontario, is a use-
ful reference for planning and implementing similar 
concepts elsewhere.14-16 Chemotherapy medication 
errors are not uncommon in the developed world and 
the same methods to minimize these occurrences ap-
ply in less developed countries. Accurate and legible 
Strengths Weaknesses Opportunities Threats
- Common language
- Government support
- Less bureaucracy
- Strong personal values
- Strong belief in Western          
  medicine and science
- Openness to outside 
  suggestions
- Desire to improve situation/ 
  self criticism
- Language difficulties
- Understanding culture
- Lack of organizational 
  structure
- Isolation
- Professional shortage
- Treatment cost
- Establishing trust
- Technical support
- Key contacts with 
  government and business
- Technology jump
- Strong family and tribal units
- High illiteracy
- Geographic Isolation 
- Low GDP
- Personalization of 
  misfortune
- Technologies disrupt basic 
   values
- Corruption
- resistance to change
Table 2. A SWOT* analysis for developing an oncology program in Yemen.
Table 3. Priority ranking for treating pediatric cancers in a Pakistani hospital with US survival rates.
Disease
Percentage 
distribution of 
cancers (%)
Long-term survival 
(%) Cost
5-year relative 
survival USA 1985-
1994 (%)
Acute lymphoblastic leukemia 25 60 Intermediate 77
Hodgkin’s lymphoma 10 90 Low 91
Non-Hodgkin’s lymphoma 10 65 Intermediate 71
Germ cell tumor 3 80 Low 88
Wilms’ tumor 5 80 Low 92
retinoblastoma 6 70 Low 94
rhabdomyosarcoma and 
neuroblastoma, or NBS (non-
metastatic)
5 30 High 64 (NBS)
Brain tumors: selected non-
metastatic and low grade 3 50 Intermediate Various
Osteosarcoma (non-
metastatic) 3 40 High 63
Would not treat
Acute myelogenous leukemia 5 <10 Very high 41
Stage IV neuroblastoma and 
sarcoma 15 <10 Very high -
relapsed disease and others 10 <10 Very high -
Source: Personal communication, m.S. Ashraf, Children Cancer Hospital, Karachi, Pakistan. march 2006; ries et al (1999)
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records, pharmacy and nursing checks of physician 
orders are useful and could eventually be improved 
with the use of oncology care software. 
5.  Enhancing the training and number of positions 
for cancer-related health professions. The highest 
training priorities include pathology technologists, 
pathologists, surgeons, and pediatric oncologists. 
Specialty training is best done using high quality 
more cost-effective regional training programs in the 
Middle East. 
6.  Establishing a medical records system to monitor the 
effectiveness of cancer control. 
7.  Drug costs are a major concern. Prioritization of the 
most effective treatments is necessary. Suggested 
examples for pediatric and adult cancers have been 
published in the Institute of Medicine publica-
tion on Cancer Control Opportunities in low and 
middle income countries in 2007.2 Thresholds for 
public funding for these agents will depend on eco-
nomic conditions and the relative importance of 
benefits in Yemeni society. 
8.  Treatment will often be ineffective if compliance is 
poor due to inadequate education of patients and 
families, or if accessibility is an issue due to finances 
or geographic isolation. Monitoring whether patients 
are getting prescribed treatments, especially for cur-
able cancers is fundamental, including the implemen-
tation of measures to rectify deficiencies. 
9.  Adequate resources must be available for symptom 
control and palliation. Narcotic analgesia is pre-
scribed by physicians at the NOC but it is difficult 
to obtain elsewhere. Yemen remains one of the low-
est users per capita of morphine in the world.17 The 
ability to prescribe narcotic analgesics should be ex-
panded in a controlled fashion so that they are avail-
able from local sources. 
10.  It is easy for health care providers to become dis-
couraged. Cancer care providers require support 
and ongoing encouragement including regular re-
views of progress and continuing medical education 
programs relevant to them. We have therefore unof-
ficially twinned many of our staff at the London 
Regional Cancer Program in Ontario with those in 
the NOC. This has resulted in many strong per-
sonal ties with our Yemeni colleagues. A vision and 
mission statement is necessary to focus resources. 
To maintain sustainability, the CMD is making site 
visits twice yearly. 
11.  The current administrative medical leadership at 
the NOC is overwhelmed at many levels because 
of the magnitude of their complex task, the pace of 
change and societal values that do not fully support 
the delegation of duties. Administrative mentor-
ships for the director of the NOC and other senior 
administrators should be helpful. Administrative 
flow charts with responsibilities and clear job de-
scriptions have been created for managerial posi-
tions. This will allow the current Director time to 
focus on executive planning and decisions. 
12.  Public education is extremely important for pre-
vention and early detection. General measures 
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Figure 1. Frequency (%) of different cancers in males and females,  recorded (i)in the 
cancer registry of Aden (2001-4), (ii) patients from 2 regions of the country (“centre” and 
“coast”) from the NOC (Sanaa) registry (2004) and (iii) in the Hadramout registry (2002-
2006). Figures compiled by A Bawazir, 2008.
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to assure people that cancer is not a punishment 
but rather, a natural event that can affect anyone 
may reduce some of the reluctance to disclose. 
Children are an important vehicle to educate par-
ents. In the course of a recent visit to Sana’a, we 
found that text messaging was an effective way to 
encourage women to attend breast health clinics. 
Trusted local community “healers” can also be an 
important resource to coordinate cancer educa-
tion and health promotion activities. 
13.  It may be cost effective to undertake extensive 
prevention programs in some areas. Based on 
current evidence, these might include: 
  •  Hepatitis B vaccination program (National 
Program in place in cooperation with 
UNICEF). 
  •  Educational programs on the dangers of to-
bacco. Yemen signed the WHO framework 
convention on tobacco control in February, 
2007.18 Public health measures as per the 
WHO convention should be considered. 
  •  A program to encourage breast self-exami-
nation. A comprehensive mammography 
screening program is difficult to consider at 
this time based on financial, technical and 
human resource constraints. 
  •  A screening program for cervical cancer 
awaits further development of pathology in-
frastructure and public education. Education 
could be integrated into women’s health pro-
grams. Vaccines are currently too expensive. 
  •  Improvement in general living conditions 
should eventually result in a decline in stom-
ach cancer. 
Conclusions
We believe that it is premature to attempt to evaluate 
outcomes. The establishment of a National Oncology 
Program with regional access to NOC treatment centres 
is the first step. We are encouraged by the steps taken by 
the Ministry of Health to fund the NOP, the establish-
ment of a Cancer Board, its signing of the WHO frame-
work convention on tobacco control and its support of 
the hepatitis vaccination program. We have also been 
extremely appreciative of the support that the Program 
has officially received from the government of Yemen, 
the health professionals working at the NOC and pro-
fessionals in other major cities in the country. The next 
critical steps will include development of the National 
Oncology Program outlining the scope of cancer control, 
prioritization of objectives and the development of indi-
cators to evaluate the success attaining objectives. 
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